glutathione mutations in sclc patients Inhibiting the system xC−/glutathione axis selectively targets cancers with mutant-p53 accumulation Oncology Letters
Oncology Letters Tumor suppressor genes and KRAS G12C inhibitor resistance in non small cell lung cancer: iScience Differential KEAP1 NRF2 mediated signaling widens the therapeutic window of redox targeting drugs in SCLC therapy Nature Communications The role of ERBB4 mutations in the prognosis of advanced non small cell lung cancer treated with immune checkpoint inhibitors Molecular Medicine Springer Nature Link Impact of the deletion glutathione S transferase (class Mu) on lung cancer risk among smokers The Egyptian Journal of Bronchology Springer Nature Link Glutathione Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy ACS Omega
Pay in 4 interest-free payments of $6.72 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29





